ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
A report of herpetic necrotizing keratitis following coronavirus disease 2019 infection.
Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpetic necrotizing keratitis is a severe ocular manifestation of herpes simplex virus (HSV) infection, often leading to significant visual impairment. We report a case of a 65-year-old female who presented with ocular pain and reduced acuity in the left eye, 2 weeks after a coronavirus disease 2019 (COVID-19) infection, with a relevant history of a herpetic keratitis three decades prior. Examination revealed necrotizing keratitis with stromal necrosis, dendritic epithelial defect, corneal neovascularization, and diffuse conjunctival injection. This was managed concurrently with topical and systemic aciclovir, and topical prednisolone was introduced at the 2-week mark. Recovery to good visual function and resolution of symptoms was achieved. This is a rare case of herpetic necrotizing keratitis following COVID-19 infection and likely represents a reactivation of the latent HSV type 1 by Severe acute respiratory syndrome coronavirus 2. This case emphasizes the importance of recognizing and managing inflammatory ocular complications in individuals with a history of herpetic infections and highlights another potential repercussion of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.